Search Results - "Nir, Eyal"

Refine Results
  1. 1

    Research ethics and public trust in vaccines: the case of COVID-19 challenge trials by Eyal, Nir

    Published in Journal of medical ethics (01-04-2024)
    “…Despite their clearly demonstrated safety and effectiveness, approved vaccines against COVID-19 are commonly mistrusted. Nations should find and implement…”
    Get more information
    Journal Article
  2. 2

    How to Address the Risk of HIV Transmission in Remission Studies With Treatment Interruption: The Low-Hanging Fruit Approach by Eyal, Nir

    Published in The Journal of infectious diseases (02-07-2019)
    “…Abstract Some HIV remission studies include a treatment interruption that seriously risks infecting participants’ sex partners with HIV. What, ethically, is…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Removing One Barrier to Protecting Sex Partners in HIV Remission Studies With a Treatment Interruption by Eyal, Nir

    Published in The Journal of infectious diseases (02-07-2019)
    “…Abstract Only a few of the recommendations made in this supplement are implemented in ongoing HIV remission studies that involve an analytical treatment…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure by Eyal, Nir, Lipsitch, Marc, Smith, Peter G

    Published in The Journal of infectious diseases (11-05-2020)
    “…Abstract Controlled human challenge trials of SARS-CoV-2 vaccine candidates could accelerate the testing and potential rollout of efficacious vaccines. By…”
    Get full text
    Journal Article
  7. 7

    Risk to bystanders in clinical trials: A symposium by Eyal, Nir

    Published in Clinical trials (London, England) (01-10-2019)
    “…This symposium takes a critical look at the ethics of impact on “bystanders” to clinical research. By that we mean study non-participants who nevertheless are…”
    Get full text
    Journal Article
  8. 8

    The Ethics of Human Challenge Trials Using Emerging Severe Acute Respiratory Syndrome 2 Variants by Rohrig, Abie, Eyal, Nir

    Published in The Journal of infectious diseases (15-03-2022)
    “…The world's first coronavirus disease 2019 human challenge trial using the D614G strain of severe acute respiratory syndrome 2 (SARS-CoV-2) is underway in the…”
    Get full text
    Journal Article
  9. 9

    Study bystanders and ethical treatment of study participants—A proof of concept by Eyal, Nir

    Published in Bioethics (01-11-2020)
    “…ABSTRACT The ethics of research on human subjects is often construed as a fine balance between the interests of patients in need of novel health interventions,…”
    Get full text
    Journal Article
  10. 10

    Improving vaccine trials in infectious disease emergencies by Lipsitch, Marc, Eyal, Nir

    “…Unprecedented global effort is under way to facilitate the testing of countermeasures in infectious disease emergencies. Better understanding of the various…”
    Get full text
    Journal Article
  11. 11

    When offering a patient beneficial treatment undermines public health by Eyal, Nir, Williams, Bridget

    Published in Bioethics (01-11-2023)
    “…Abstract Sometimes, offering someone beneficial care is likely to thwart the similar or more serious medical needs of more people. For example, when acute…”
    Get full text
    Journal Article
  12. 12

    Ethical and legal race-responsive vaccine allocation by Steuwer, Bastian, Eyal, Nir

    Published in Bioethics (01-10-2023)
    “…In many countries, the COVID-19 pandemic varied starkly between different racial and ethnic groups. Before vaccines were approved, some considered assigning…”
    Get full text
    Journal Article
  13. 13

    Is it ethical to isolate study participants to prevent HIV transmission during trials with an analytical treatment interruption? by Eyal, Nir, Magalhaes, Monica

    Published in The Journal of infectious diseases (02-07-2019)
    “…Abstract This commentary considers an extreme idea for protecting against human immunodeficiency virus (HIV) transmission to sex partners of individuals…”
    Get full text
    Journal Article
  14. 14

    Risk to Nonparticipants in HIV Remission Studies With Treatment Interruption: A Symposium by Eyal, Nir, Deeks, Steven G

    Published in The Journal of infectious diseases (02-07-2019)
    “…Abstract Ethical guidelines and recommendations for human subjects research typically focus on protecting the individuals who directly participate in that…”
    Get full text
    Journal Article
  15. 15

    Input and output in distributive theory by Eyal, Nir, Herlitz, Anders

    Published in Noûs (Bloomington, Indiana) (01-03-2023)
    “…Distributive theories evaluate distributions of goods based on candidate recipients’ characteristics, e.g. how well off candidates are, how deserving they are,…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Do coronavirus vaccine challenge trials have a distinctive generalisability problem? by Eyal, Nir, Gerhard, Tobias

    Published in Journal of medical ethics (01-09-2022)
    “…Notwithstanding the success of conventional field trials for vaccines against COVID-19, human challenge trials (HCTs) that could obtain more information about…”
    Get more information
    Journal Article
  18. 18

    Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines by Steel, Robert, Buchak, Lara, Eyal, Nir

    Published in Journal of medical ethics (01-12-2020)
    “…To counter the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), some have proposed accelerating SARS-CoV-2 vaccine development…”
    Get more information
    Journal Article
  19. 19

    The phantasm of zero suicide by Sjöstrand, Manne, Eyal, Nir

    Published in British journal of psychiatry (01-06-2023)
    “…Governments and non-governmental organisations are increasingly adopting a ‘zero-suicide’ goal, but what such a goal precisely involves is unclear. Ostensibly…”
    Get full text
    Journal Article
  20. 20